Comprehensive Genetics & Genetic Counseling Notes

  • Gene-Based Therapies

  • • Gene-replacement therapy – experimental insertion of healthy genes to treat / prevent disease.
    • Gene editing (site-specific nucleases) – DNA segments are inserted/deleted/modified/replaced\text{inserted} / \text{deleted} / \text{modified} / \text{replaced} at pre-chosen loci (e.g., CRISPR-Cas9).
    • Nursing relevance: monitoring informed consent, explaining experimental nature, assessing psychosocial impact.

  • Basic Genetic Terminology

  • • Gene – basic unit of heredity; segment of DNA encoding a protein / functional RNA.
    • Genome – complete genetic complement (≈ 50 000–100 00050\,000\text{–}100\,000 genes).
    • Chromosome – DNA + protein “storage unit” inside nuclei (humans: 4646, i.e., 2222 autosomal pairs + 11 sex-chromosome pair).
    • Alleles – alternative versions of a gene occupying the same locus on homologous chromosomes.
    • Genotype – actual allele combination; phenotype – observable expression.
    • Homozygous AA / aaAA\,/\,aa; heterozygous AaAa.
    • Dominant vs. recessive – dominant allele expressed with only one copy; recessive visible only when both alleles are recessive.

  • Mendelian Principles (Gregor Mendel)

  • • Law of Dominance – dominant trait masks recessive in F1F_1.
    • Law of Segregation – allele pairs separate during gametogenesis (basis for 12\frac{1}{2} gene transmission).
    • Law of Independent Assortment – different gene pairs assort independently during meiosis (except linked genes).

  • Medical Genetics – Inheritance Patterns

  • • Autosomal dominant – vertical pedigree, males = females, 50%50\% transmission risk; e.g., Huntington disease, Marfan syndrome, osteogenesis imperfecta, BRCA-related breast/ovarian CA.
    • Autosomal recessive – horizontal pedigree, parents usually carriers; disease in 25%25\% of offspring when both are carriers; e.g., cystic fibrosis (CF), PKU, Tay-Sachs, sickle cell.
    • X-linked dominant – affected mothers transmit to ≈50%\approx 50\% of sons & daughters; affected fathers transmit to all daughters/ no sons; e.g., Alport syndrome.
    • X-linked recessive – predominantly males affected; carrier mothers → 50%50\% affected sons, 50%50\% carrier daughters; e.g., hemophilia A, Duchenne MD, color-blindness, Fragile X (defective long arm).
    • Multifactorial (polygenic) – multiple genes + environment (heart disease, DM, cleft palate, NTDs, pyloric stenosis).

  • Chromosomal & Cytogenetic Concepts

  • • Cytogenetics – microscopy-based chromosome study; standard tool = karyotype (photographic arrangement).
    • FISH (fluorescence in situ hybridisation) – rapid probe-based detection of chromosome number / specific gene loci.
    • Chromosomal abnormality – numeric or structural defect producing missing / duplicated / rearranged genes.

  • Numeric Abnormalities – Nondisjunction

  • • Uneven meiotic split → gamete with 2424 or 2222 chromosomes.
    • Fertilisation yields zygote with 4747 (trisomy) or 4545 (monosomy).
    • Risk ↑ with maternal age (> 3535) & paternal age (> 5555).
    • Classic outcomes: Trisomy 21 (Down), Trisomy 18 (Edwards), Trisomy 13 (Patau), Turner (45,X), Klinefelter (47,XXY).

  • Structural Abnormalities

  • • Deletion – segment lost; eg. Cri-du-chat (5p-) → cat-like cry.
    • Translocation – segment moves to non-homologous chromosome; can create balanced carriers & unbalanced offspring (e.g., Robertsonian translocation causing familial Down syndrome).
    • Isochromosome – horizontal, not vertical, centromere split → arms duplicated/missing (Turner variant).
    • Mosaicism – post-zygotic nondisjunction → two or more karyotypes within one individual; severity linked to proportion of abnormal cells.

  • Specific Chromosomal Syndromes

  • • Down Syndrome – Trisomy 21 (47,XX,+21 / 47,XY,+21)
    – Incidence ≈1/800\approx 1/800 births.
    – Phenotype: flat facial profile, epicanthal folds, upward palpebral fissures, Brushfield spots, protruding tongue, hypotonia, single palmar (simian) crease, wide sandal gap, congenital heart disease (AV canal), ↑ risk childhood leukemia & Alzheimer-like dementia.
    • Edward’s Syndrome – Trisomy 18
    – SGA, clenched fists w/ overlapping fingers, rocker-bottom feet, micrognathia, CHD; most die in infancy.
    • Patau Syndrome – Trisomy 13
    – Midline defects (holoprosencephaly, cleft lip/palate), microphthalmia, polydactyly, severe ID; survival rarely > few months.
    • Turner Syndrome – 45,X
    – Short stature, webbed neck, low posterior hairline, broad chest w/ widely-spaced nipples, streak ovaries (infertility), coarctation of aorta, renal anomalies; treat with growth hormone + estrogen.
    • Klinefelter Syndrome – 47,XXY
    – Tall males, small testes, azoospermia, gynecomastia (↑ breast CA risk), decreased facial/body hair; testosterone therapy.
    • Fragile X (Xq27.3 fragile site)
    – Most common inherited cognitive disability in males; CGG expansion → FMR1 silencing; long face, large ears, macro-orchidism after puberty, hyperactivity / autism-spectrum behaviors.
    • Cri-du-chat – 5p deletion
    – Cat-like cry, microcephaly, hypertelorism, severe ID.

  • Gene–Cancer Associations in Children

  • • Down syndrome predisposes to acute lymphoblastic leukemia, Hirschsprung disease, & early Alzheimer pathology.
    • Retinoblastoma (RB1 gene, 13q14) – heritable bilateral tumors; early leukocoria; TNM staging used.
    • Wilms’ tumor (WT1/WT2, chr 11p13/15) – nephroblastoma, peak 33–44 yrs.
    • Neuroblastoma (N-Myc amplification) – malignant neural crest tumor, adrenal or paraspinal sites, may cause Horner’s syndrome, paraneoplastic HTN.

  • Genetic Counseling

  • • Purposes: provide accurate inheritance information, support reproductive decision-making, offer psychosocial support.
    • Prime candidates: couples with prior affected child, carriers of balanced translocations or inborn metabolic errors, consanguineous unions, advanced maternal (> 3535) or paternal (> 5555) age, high-risk ethnicities (e.g., G6PD deficiency in Asians, thalassemia in Mediterranean).
    • Nursing roles:
    – Explain screening / diagnostic procedures & timing.
    – Facilitate informed consent; clarify values without imposing personal opinions.
    – Support during result waiting & subsequent decision processes.

  • Assessment for Genetic Disorders

  • • History – 3-generation pedigree, ethnicity, maternal age, previous miscarriages (≈ 50%50\% of 1st-trimester losses genetic).
    • Physical exam cues – dysmorphic facies, palmar creases, ear placement, limb digits, dermatoglyphics, hair whorls.

  • Laboratory & Prenatal Diagnostic Tests

  • • Karyotype – culture lymphocytes to metaphase, stain (e.g., G-banding) and photograph.
    • FISH – fluorescent probes detect aneuploidy / microdeletion without cell culture.
    • Maternal Serum Screening (2nd trimester):
    – Alpha-fetoprotein (AFP) ↑ ⇒ open neural-tube defect; ↓ ⇒ Trisomy 21/18.
    – Additional analytes (hCG, unconjugated estriol, inhibin-A) refine risk (quad screen).
    • Chorionic-villi sampling (CVS) – 99–1414 wks; transcervical / transabdominal biopsy of placental villi for DNA/karyotype; risk <1%<1\% miscarriage.
    • Amniocentesis – 1414–1616 wks; aspirate ≈20 mL\approx 20\,mL amniotic fluid; culture fetal cells.
    • Percutaneous umbilical blood sampling (PUBS) / cordocentesis – ≥17\ge17 wks; sample fetal vein for rapid karyotype / hematology.

  • Key Ethical & Practical Considerations

  • • Informed consent & autonomy paramount; results can affect insurance / employment.
    • Duty to protect privacy of genetic information.
    • Potential psychological impact: guilt, anxiety, altered family dynamics.
    • Equity issues – access to advanced testing & gene therapies.